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CASE REPORT
Metastatic choriocarcinoma in a young 
woman presenting as thyroid storm: a case 
report
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Abstract 
Background: Thyroid storm is an endocrine emergency and life-threatening condition discovered in 1926. There 
is no specific laboratory parameter that can differentiate or distinguish between thyroid storm and primary hyper-
thyroidism. Diagnosis is made on a clinical scoring system, including the Burch–Wartofsky point scale and Japanese 
Thyroid Association scoring system. The management is early diagnosis, immediate initiation of anti-thyroid medica-
tions, intensive care monitoring, and prevention of multiorgan failure.
Case presentation: A 30-year-old Pakistani female presented with complaint of headache, vomiting, and general-
ized weakness for 3 weeks. She had an episode of seizure-like activity at home, and so was rushed to the emergency 
department. A detailed thyroid examination revealed a soft, nontender gland with no enlargement or bruit and no 
exophthalmos. Her thyroid-stimulating hormone was extremely low, with high free triiodothyronine and thyroxine. 
Thyroglobulin was 425 ng/ml (normal reference range ≤ 55 ng/ml), and thyroid-stimulating hormone receptor anti-
body was 0.87 IU/L (normal reference range 0–1.75 IU/L). She had high levels of beta-human chorionic gonadotropin 
hormone on initial presentation. Transvaginal ultrasound showed no intrauterine pregnancy, but an echogenic focus 
was found adherent to the right ovary with no vascularity. With the chief complaint of headache, she underwent 
magnetic resonance imaging of the brain that showed multiple scattered hemorrhagic lesions in supratentorial and 
infratentorial brain parenchyma that were highly suspicious for metastases. Computed tomography scan of the chest, 
abdomen, and pelvis revealed multiple neoplastic lesions in the lung, liver, spleen, and kidneys. A Tru-Cut liver biopsy 
showed linear cores of liver tissue with metastatic carcinoma with morphological features consistent with choriocar-
cinoma. Our patient scored 65 on the Burch–Wartofsky point scale. As per the Japanese Thyroid Association scoring 
system, our patient met the criteria for a “definite thyroid storm.” She had initiated propranolol to achieve adequate 
control of her heart rate and dexamethasone. Carbimazole was started to control her thyroid function. Her thyroid 
function after 2 weeks of treatment showed significant improvement. Methotrexate and etoposide were given for 
choriocarcinoma. She made a good recovery and was discharged home. She will undergo rehabilitation along with 
ongoing chemotherapy (methotrexate and etoposide weekly till beta-human chorionic gonadotropin levels normal-
ize). Unless her source of beta-human chorionic gonadotropin is carefully under control, she will continue to take 
anti-thyroid medications.
Conclusion: Choriocarcinoma is not only associated with hyperthyroidism but can induce thyroid storm. Beta-
human chorionic gonadotropin is directly associated with promoting thyroid dysfunction. Patients with gestational 
trophoblastic disease should be under close surveillance to prevent thyroid storms.
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Background
Thyroid storm is an endocrine emergency and life-
threatening condition discovered in 1926 [1]. There is 
no specific laboratory parameter that can differentiate or 
distinguish between thyroid storm and primary hyper-
thyroidism [2]. Diagnosis is made on a clinical scoring 
system, including the Burch–Wartofsky point scale and 
Japanese Thyroid Association scoring system [3]. The 
management is early diagnosis, immediate initiation 
of anti-thyroid medications, intensive care monitor-
ing, and prevention of multiorgan failure [4]. Here we 
report a case of thyroid storm in a patient with metastatic 
choriocarcinoma.
Case presentation
A 30-year-old Pakistani female, married, mother of two 
children, presented to the emergency department in May 
2021 with complaint of headache, vomiting, and general-
ized weakness for 3 weeks. She had an episode of seizure-
like activity at home, and so was rushed to the emergency 
department. Headache is defined as generalized pain 
mainly over the vertex that has gradual onset and is dull 
in nature, nonradiating, intermittent in duration with 
days going through worst pain followed by days without 
pain, moderate in severity ranging from 7 to 8 on a pain 
scale, and associated with nausea, vomiting, and general-
ized weakness. It was only temporarily relieved with pain 
medications. There was no stress precipitant in her life 
to induce a headache. The single episode of seizure-like 
activity included up-rolling of eyes and drooling of saliva, 
with no generalized recognizable altered limb move-
ments and no urinary or fecal incontinence. It was fol-
lowed by a few minutes of unconsciousness. After gaining 
consciousness, she exhibited confusion and altered men-
tal status. She also had an undocumented fever, without 
chills and rigors, which was relieved with antipyretic. The 
patient denied any neck stiffness, irrelevant behavior and 
mood changes, vision alteration, excess lacrimation, and 
photo- or phonosensitivity. In addition to this, she lost 
her appetite and felt like she was losing weight, although 
her bowel and urine habits were usual. The rest of the 
systemic review was unremarkable. Her past medical his-
tory was significant for two cesarean sections, with the 
last-born child in January 2021. She had no menstruation 
after the delivery. Occasionally, she took paracetamol 
(acetaminophen) for pain relief and fever. She negated 
smoking or any other addictions. There was no history of 
allergies to particles, food, or any medications.
On physical examination, she was agitated and acutely 
anxious but still awake, alert, and oriented to time, 
place, and person. Her Glasgow Coma Scale score was 
15 over 15. Initial blood pressure was 138/72  mmHg, 
heart rate was 105  beats per minute, respiratory rate 
was 22  breaths per minute, and temperature was 
38.0 °C. Jugular venous pressure was not distended, and 
there was no appreciable peripheral edema and lymph 
node enlargement. Cardiac examination showed tach-
ycardia with a regular pulse, and there were no added 
sounds. Respiratory examination revealed distant air 
entry in bilateral lung fields. No crepitation or wheezes 
were noted. Abdominal examination was insignifi-
cant with no organomegaly. Neurological examina-
tion depicted confusion with normal speech, delay to 
response, equally reactive pupils, intact cranial nerves, 
no motor or sensory deficit, normal reflexes, and down-
going plantar response. A detailed thyroid examination 
revealed a soft, nontender gland with no enlargement 
or bruit and no exophthalmos. Gynecological examina-
tion revealed a horizontal scar in the pelvis of the pre-
vious C-section, with normal external genitalia and no 
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Table 1 Initial laboratory parameters of the patient
SGPT/ALT: Serum glutamic pyruvic transaminase/Alanine aminotransferase; 
SGOT/AST: Serum glutamic oxaloacetic transaminase/Aspartate 
aminotransferase; TSH: thyroid stimulating hormone; Beta-hCG: Beta-human 
chorionic gonadotropin
Value Reference range
Hemoglobin 10.1 g/dl 11–14.5
White cell count 8.2 ×  109/L 4.6–10.8 ×  109
Platelets 223 ×  109/L 154–433 ×  109
Creatinine 0.7 mg/dl 0.6–1.1
Sodium 132 mmol/L 136–145
Potassium 3.9 mmol/L 3.5–5.1
Bicarbonate 22.7 mmol/L 20–31
Calcium 8.6 mg/dl 8.6–10.2
Magnesium 1.8 mg/dl 1.6–2.6
SGPT/ALT 67 IU/L < 35
SGOT/AST 114 IU/L < 31
International normalized ratio 1.0 0.9–1.2
C-reactive protein 32.39 mg/L 0–14
Procalcitonin 0.219 ng/ml > 2
TSH < 0.010 uIU/ml 0.4–4.2
Free T4 4.74 ng/dl 0.89–1.76
Free T3 17.90 pg/ml 2.1–4.4
Beta-hCG 3,058,000 IU/ml Nonpregnant: < 10
Troponin I (initial) 1.485 ng/ml > 0.04
Troponin I (after 6 hours) 0.856 ng/ml –
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vaginal mass, discharge, or atrophy on speculum exam-
ination. The uterus was anteverted and had multiple 
blood clots in the cervical canal.
Based on history and examination, she underwent 
an extensive investigation to identify the cause of her 
illness. Due to the ongoing pandemic, severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2) 
antigen test and polymerase chain reaction were done, 
which came back negative. Initial complete blood count 
and metabolic panel were insignificant (Table 1).
Her thyroid-stimulating hormone (TSH) was extremely 
low, with high free triiodothyronine (T3) and thyroxine 
(T4), warranting us to perform more investigations to 
identify the cause. Thyroglobulin was 425  ng/ml (nor-
mal reference range ≤ 55 ng/ml), and TSH receptor anti-
body (TRAb) was 0.87  IU/L (normal reference range 
0–1.75  IU/L). Due to high levels of beta-hCG hormone 
on initial presentation, she underwent a transvaginal 
ultrasound that showed no intrauterine pregnancy but 
an echogenic focus adherent to the right ovary with no 
vascularity. The finding could be secondary to ectopic 
pregnancy versus neoplastic lesion (Fig.  1). With the 
chief complaint of headache, she underwent magnetic 
resonance imaging (MRI) of the brain that showed mul-
tiple scattered hemorrhagic lesions in supratentorial and 
infratentorial brain parenchyma that were highly suspi-
cious for metastases with an unknown primary (Fig.  2). 
Computed tomography (CT) scans of the chest, abdo-
men, and pelvis were done to identify the primary tumor 
and for the staging of the disease. The scan revealed 
multiple neoplastic lesions in the lung, liver, spleen, and 
kidneys (Fig. 3a, b). She then underwent a Tru-Cut liver 
biopsy that showed linear cores of liver tissue with meta-
static carcinoma with morphological features consistent 
with choriocarcinoma.
Thyroid storm was diagnosed based on the clinical 
scoring system proposed by Burch and Wartofsky, which 
is the most widely used [5]. Our patient scored 65 on the 
Burch–Wartofsky point scale (Table 2). A score of more 
than 45 is highly suggestive of thyroid storm. As per the 
Japanese Thyroid Association scoring system [6], our 
patient met the criteria for “definite thyroid storm” with 
thyrotoxicosis and one feature of the central nervous 
system (seizures) along with fever and gastrointestinal 
manifestations.
The patient was initially admitted to a special care 
unit, but later she developed generalized tonic–clonic 
seizures that were not aborted with diazepam and antie-
pileptic medications. The patient went into status epilep-
ticus and so was electively intubated, was sedated with 
propofol and midazolam, and was shifted to the intensive 
care unit. The oncology team was called and advised of 
additional work-up before proceeding towards chemo-
therapy. Her serum alpha-fetoprotein was 2.0  IU/ml 
(normal reference range < 6.7  IU/ml), whereas human 
immunodeficiency virus (HIV) serology and hepatitis B 
and C came out to be nonreactive. Interestingly, echo-
cardiography was done showing preserved ejection frac-
tion (60%) with no segmental wall motion abnormality. A 
mobile, finger-like echogenic density was noted in the left 
atrium, probably attached to the pulmonary vein, which 
is suggestive of thrombus or mass or vegetation (Fig. 4). 
Her blood cultures were negative, and there was no his-
tory of joint pain and rash, making infective endocardi-
tis less likely. The cardiology team was called, and they 
considered it as a part of ongoing systemic disease. Her 
creatinine clearance was 73 ml/minute (normal reference 
range 65–123 ml/minute). For choriocarcinoma, she was 
started on multiple chemotherapy regimen of methotrex-
ate and etoposide.
Endocrine team was consulted during the intensive 
care unit (ICU) stay. She had already been initiated on 
propranolol 20  mg every 8  hours to achieve adequate 
control of her heart rate and dexamethasone 10 mg every 
8 hours by the ICU team. She was also started on carbi-
mazole 15  mg every 12  hours. She was then started on 
cholestyramine 4 g every 6 hours to help bind and excrete 
excess thyroid hormone and Lugol’s iodine solution (ten 
drops every 8 hours). The results of her thyroid function 
test repeated after 2 weeks of treatment are presented in 
Table 3.
During ICU stay, her Glasgow Coma Scale (GCS) 
score dropped from 15/15 to 5/15, so urgent CT of the 
head was done, which showed diffuse cerebral edema 
with midline shift. Neurosurgery team was called, and 
she was started on hypertonic saline. Later, she under-
went decompressive craniotomy for her brain lesion to 
reduce mass effect and tracheostomy for prolonged res-
piratory support. She was then transitioned to a portable Fig. 1 Transvaginal ultrasound showing an echogenic focus (shown 
by white arrow) adherent to right ovary with no vascularity
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Fig. 2 Magnetic resonance imaging of the brain showing scattered hemorrhagic lesions in supratentorial and infratentorial brain parenchyma as 
shown with white arrows 
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Fig. 3 a Computed tomography of the chest showing neoplastic lesions in the lung (white and black arrows). b Computed tomography of the 
abdomen and pelvis (white and black arrows) showing multiple neoplastic lesions in liver, spleen, and kidneys
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ventilator, which she tolerated well and so was shifted out 
of the intensive care unit.
She made a good recovery and was gradually tapered 
off the sedation. Antiepileptic medications were further 
optimized by the neurology team, and she was gradually 
weaned off the ventilator. She was successfully discharged 
home and planned to undergo rehabilitation along with 
ongoing chemotherapy (methotrexate and etoposide 
weekly till beta-hCG level normalize). Unless her source 
of beta-HCG is carefully under control, she will continue 
to take anti-thyroid medications.
Discussion
We report here an interesting case of a middle-aged 
female with metastatic choriocarcinoma presenting with 
thyroid storm.
Thyroid storm is a rare and life-threatening endocrine 
emergency. Mortality with thyroid storm is around 30%. 
It is considered to be precipitated by physiological stress 
caused by surgery, trauma, infections, metabolic acidosis, 
and uncontrolled hyperthyroidism [7]. Pregnancy and 
childbirth are also considered triggering factors for thy-
roid storms [8]. Our patient also had a recent cesarean 
section, making her prone to having thyroid storm.
The clinical features used for diagnosing thyroid storm 
include fever, tachycardia, central nervous system (CNS) 
manifestation, gastrointestinal (GI) manifestations, car-
diac manifestations, and precipitating events [5, 6]. Fever 
and tachycardia were present in our patient. CNS mani-
festations include altered mental status, agitation, psy-
chosis, seizures, and coma. GI manifestations include 
jaundice, nausea, vomiting, and abdominal pain [9]. Our 
Table 2 Burch–Wartofsky point scale (BWPS)
Patient parameters Point scores
Temperature (°C) 38 °C 10 points
Central nervous system manifestation Seizures 30 points
Gastrointestinal manifestation Nausea/vomiting 10 points
Heart rate 105 beats per minute 5 points
Congestive heart failure Absent 0 points
Atrial fibrillation Absent 0 points
Precipitating events Present 10 points
Total score = 65 points
Fig. 4 Echocardiography showing mobile, finger-like echogenic density in left atrium shown with white arrow
Table 3 Thyroid profile of the patient
TSH: thyroid stimulating hormone
Initial After treatment (2 weeks) Reference range
TSH < 0.010 uIU/ml < 0.010 uIU/ml 0.4–4.2
Free T4 4.74 ng/dl 1.61 ng/dl 0.89–1.76
Free T3 17.90 pg/ml 3.40 pg/ml 2.1–4.4
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patient had a seizure that was not aborted by antiepi-
leptics. This could be an overlapping symptom between 
thyroid storm or brain metastasis. She had vomiting with 
mild hepatic dysfunction.
Pituitary tumors secreting thyroid-stimulating hor-
mone are also unusual. They usually present with hyper-
thyroidism. Fujio et  al. reported a case from Japan of 
thyroid storm with TSH-secreting pituitary malignancy 
[10]. Various case reports show an association between 
gestational trophoblastic disease and thyroid storm. 
Females of childbearing age are at high risk and should 
be evaluated to prevent fatal outcomes [11, 12]. Here, we 
also report a case of disseminated gestational trophoblas-
tic disease presenting with thyroid crises.
Gestational trophoblastic disease (GTD) is a group 
of disorders that includes benign conditions (such as 
hydatidiform mole) and malignant conditions (such as 
invasive mole, choriocarcinoma, placental site, and epi-
thelioid trophoblastic tumor) [13]. The pathophysiology 
of thyroid disease with gestational trophoblastic dis-
ease is secretion of beta-human chorionic gonadotropin 
(hCG) hormone by trophoblastic tissue. The two known 
main mechanisms of thyroid disorder with increased 
beta-hCG are enhanced thyrotropic activity by beta-hCG 
and structural resemblance with TSH causing a release 
of thyroxine from the thyroid gland [14]. Kofinas et  al. 
reported a beta-hCG level in her patient with a thyroid 
storm of around 1,488,021  IU/ml [11]. Our patient had 
a very high level of beta-hCG (3,058,000 IU/ml), and the 
above-mentioned mechanism explains the cause of thy-
roid storm in her.
A choriocarcinoma is a malignant form of GTD. Kato 
et  al. reported an incidence of hyperthyroidism with 
choriocarcinoma of approximately 57%, while in nor-
mal pregnancy it is 18%. This was associated with high 
levels of beta-hCG as compared with normal pregnancy 
[15]. A recent case report had been published of a patient 
with testicular choriocarcinoma presenting with thyroid 
storm [16]. Morley et  al. reported three cases of meta-
static choriocarcinoma with thyrotoxicosis. They also 
postulated that higher levels of beta-hCG are associ-
ated with an increased risk of thyroid storm [17]. Sotello 
et al. reported metastatic choriocarcinoma in men with 
thyrotoxicosis [18]. Similarly, our patient was also diag-
nosed with metastatic choriocarcinoma along with thy-
roid storm. Interestingly, testicular choriocarcinoma 
was more associated with thyroid crises. In our case, the 
patient was a woman of childbearing age with a right 
ovary lesion and metastasis to the brain, lungs, liver, and 
kidneys.
Future observational studies are required for identify-
ing the incidence and prevalence of thyroid storm with 
GTD. Though hyperthyroidism is common with GTD, 
study of its outcomes in these individuals has been lim-
ited. We encourage endocrinologists and gynecologists to 
collaborate and formulate a mechanism for early identifi-
cation, proper management, and assessment of outcomes 
of thyroid storm presenting in patients with gestational 
trophoblastic disease.
Conclusion
Choriocarcinoma is not only associated with hyper-
thyroidism but can induce thyroid storm. Beta-hCG is 
directly associated with promoting thyroid dysfunction. 
Patients with gestational trophoblastic disease should be 
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